“.... Participants supplemented 3.2–6.4 g∙day−1 of chronic βA or placebo (PL) during four weeks, and acute...”
Access document (1)
Access document (2)

“... ± 6.7 to 13.8 ± 6.0 ng/mL (− 18.5%) in the placebo group (p < 0.001). There was a decrease (− 21.3%) of PTH...”
Access document (1)
Access document (2)

Subjects: “...Placebo...”
Access document

Subjects: “...Placebo...”
Access document

Access document

“... sleep were unchanged between placebo and 4-AP nights. Tonic but not phasic EMGGG during REM sleep was...”
Access document (1)
Access document (2)

“... μg/L) to week 12 (48.31 ± 20.99 μg/L) and week 24 (39.16 ± 16.50 μg/L). Placebo group, the PINP marker did not...”
Access document (1)
Access document (2)

“... placebo, and this decrease was statistically signifi cant. In the other group, we did not observe any...”
Access document

“... placebo, and this decrease was statistically significant. In the other group, we did not observe any...”
Access document (1)
Access document (2)

Subjects: “...Placebo...”
Access document

“... consistently every year, and in view of the limited number of studies investigating their effect in the elderly...”
Access document (1)
Access document (2)

Access document

“... IL-12p70 concentrations were assessed. Original article 2: This is a randomized, double-blind, placebo-controlled clinical...”
Access document

“... an increase or a decrease in the rate of death and rehospitalization and had a small, nonsignificant effect...”
Access document

Access document

“... prospectivo, randomizado, duplo cego, controlado por placebo que incluiu indivíduos acima de 18 anos...”
Access document

Access document

“... a common practice, since they decrease the incidence of these symptoms. There are no clinical data about...”
Access document

Access document

“..., controlado com placebo (Langer e cols., 2022). O tratamento com ITSL resultou em redução significante...”
Access document